Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients
Clinical trial NCT00900146 · TERMINATED
Trial details
- NCT number
- NCT00900146
- Sponsor
- Novartis
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-11-01
- Enrollment
- 556
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.